CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40.
Open Access
- 1 August 1993
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 178 (2), 669-674
- https://doi.org/10.1084/jem.178.2.669
Abstract
CD40 is a member of the tumor necrosis factor (TNF) receptor family of cell surface proteins and was originally described as a B cell restricted antigen. Treatment of primary human monocytes with granulocyte/macrophage colony-stimulating factor (GM-CSF), interleukin 3 (IL-3), or interferon gamma (IFN-gamma) resulted in the induction of CD40 mRNA and enhancement of cell surface protein expression. CD40 was found to mediate monocyte adhesion to cells expressing recombinant CD40 ligand. CD40 ligand-transfected cells provided a potent costimulus for monocyte TNF-alpha and IL-6 production in the presence of GM-CSF, IL-3, or IFN-gamma, and enhanced IL-8 production stimulated by GM-CSF or IL-3. In addition, CD40 ligand-transfected cells acting in the absence of a costimulus induced monocytes to become tumoricidal against a human melanoma cell target. Collectively, these data indicate that CD40 ligand is pleiotropic with potent biological activity on monocytes.Keywords
This publication has 25 references indexed in Scilit:
- Effect of granulocyte-macrophage colony-stimulating factor and interleukin-3 on interleukin-8 production by human neutrophils and monocytes.1993
- Cloning of TRAP, a ligand for CD40 on human T cellsEuropean Journal of Immunology, 1992
- The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity.The EMBO Journal, 1992
- Synergistic activation of human monocytes by granulocyte-macrophage colony-stimulating factor and IFN-gamma. Increased TNF-alpha but not IL-1 activity.The Journal of Immunology, 1988
- Resting B lymphocytes can be triggered directly through the CDw40 (Bp50) antigen. A comparison with IL-4-mediated signaling.The Journal of Immunology, 1988
- Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4.The Journal of Immunology, 1988
- Soluble CD23 is released by B lymphocytes cycling in response to interleukin 4 and anti‐Bp50 (CDw40)European Journal of Immunology, 1988
- Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.1987
- Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages.Proceedings of the National Academy of Sciences, 1986
- Role of interleukin 1 in promoting human monocyte-mediated tumor cytotoxicity.The Journal of Immunology, 1985